Registro completo de metadatos
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.provenance | CONICET | - |
| dc.creator | Sosnik, Alejandro Dario | - |
| dc.date | 2017-03-29T18:38:14Z | - |
| dc.date | 2017-03-29T18:38:14Z | - |
| dc.date | 2010-08 | - |
| dc.date | 2017-03-21T20:12:42Z | - |
| dc.date.accessioned | 2019-04-29T15:37:51Z | - |
| dc.date.available | 2019-04-29T15:37:51Z | - |
| dc.date.issued | 2010-08 | - |
| dc.identifier | Sosnik, Alejandro Dario; Nanotechnology contributions to the pharmacotherapy of pediatric HIV: a dual scientific and ethical challenge and a still pending agenda; Future Medicine; Nanomedicine; 5; 6; 8-2010; 833-837 | - |
| dc.identifier | 1743-5889 | - |
| dc.identifier | http://hdl.handle.net/11336/14456 | - |
| dc.identifier.uri | http://rodna.bn.gov.ar:8080/jspui/handle/bnmm/298089 | - |
| dc.description | The Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) is the most deadly infectious disease of our times. It currently affects more than 40 million people worldwide [101]. HIV is a disease of poverty as more than 80% of the patients live in developing nations and 60% in the sub-Saharan region (sSR) of Africa. Children represent approximately 6% of the infected population, though 15% of the new infections and the 15% of the nearly 2 million annual deaths. In addition, 15 million children have been orphaned due to AIDS [102]; 11.6 millions only in the sSR. Pediatric HIV has been almost eradicated in developed countries by preventing the mother-to-child-transmission (MTCT) and replacing natural delivery by caesarean. Conversely, in the developing world, 1000 new cases are registered every day. Only 10% of the HIV-positive children have appropriate access to medication, this extent decreasing dramatically to less than 2% in the sSR [103]. Thus, while HIV is gradually becoming a chronic and manageable disease in Europe and North America owing to the high activity antiretroviral therapy (HAART) or cocktail, most HIV-infected children in Africa are unfortunately sentenced to die before the two years of age. | - |
| dc.description | Fil: Sosnik, Alejandro Dario. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Tecnología Farmacéutica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | - |
| dc.format | application/pdf | - |
| dc.format | application/pdf | - |
| dc.language | eng | - |
| dc.publisher | Future Medicine | - |
| dc.relation | info:eu-repo/semantics/altIdentifier/url/http://www.futuremedicine.com/doi/10.2217/nnm.10.64 | - |
| dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.2217/nnm.10.64 | - |
| dc.rights | info:eu-repo/semantics/restrictedAccess | - |
| dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | - |
| dc.source | reponame:CONICET Digital (CONICET) | - |
| dc.source | instname:Consejo Nacional de Investigaciones Científicas y Técnicas | - |
| dc.source | instacron:CONICET | - |
| dc.source.uri | http://hdl.handle.net/11336/14456 | - |
| dc.subject | COST-VIABLE LIQUID FORMULATIONS | - |
| dc.subject | EFAVIRENZ | - |
| dc.subject | ETHICAL AFFORDABILITY | - |
| dc.subject | NEGLECTED DISEASES | - |
| dc.subject | PEDIATRIC HIV | - |
| dc.subject | SCALABLE LIQUID FORMULATIONS | - |
| dc.subject | Otras Nanotecnología | - |
| dc.subject | Nanotecnología | - |
| dc.subject | INGENIERÍAS Y TECNOLOGÍAS | - |
| dc.title | Nanotechnology contributions to the pharmacotherapy of pediatric HIV: a dual scientific and ethical challenge and a still pending agenda | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.type | info:ar-repo/semantics/articulo | - |
| Aparece en las colecciones: | CONICET | |
Ficheros en este ítem:
No hay ficheros asociados a este ítem.